BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

Point-of-care blood test detects evidence of present or past exposure in 15 minutes FRANKLIN LAKES, N.J. and MORRISVILLE, N.C., March 31, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, today announced the release of a new point-of-care test Read more…

BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease

everlinQ™ endoAVF System Receives FDA De Novo Marketing Authorization FRANKLIN LAKES, N.J., July 9, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with Read more…

en_GBEnglish
en_GBEnglish ro_RORomanian